Could a drug slow rare brain disease? new study uses Real-World data to find out

This study looks at whether the drug troriluzole can slow the progression of spinocerebellar ataxia (SCA), a rare genetic disease that affects movement and balance. Researchers will compare 909 patients who took troriluzole for up to three years with similar patients who did not receive the drug, using data from natural history studies. The main goal is to see if treated patients have less worsening on a scale that measures coordination and daily function.